Suchergebnisse - Nafiseh Ansarinejad

A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab re... von Reza Safaei Nodehi, Behjat Kalantari, Jahangir Raafat, Nafiseh Ansarinejad, Vahid Moazed, Seyed Mohammad Reza Mortazavizadeh, Mehran Hosseinzadeh, Bayazid Ghaderi, Arash Jenabian, Mojtaba Qadyani, Shirin Haghighat, Abolghasem Allahyari, Mehrzad Mirzania, Mohammad Seghatoleslami, Mehrdad Payandeh, Afsaneh Alikhasi, Hamidreza Kafi, Farhad Shahi

Connect to this object online.

A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy von Farhad Shahi, Associate Professor, Farahnaz Vafaeezadeh, Post doctoral fellowship, Nafiseh Ansarinejad, Associate Professor, Alireza Ahmadi, Post doctoral fellowship, Ali Shahriari-Ahmadi, Associate Professor, Alireza Ghazizadeh, Associate Professor, Hassanali Vahedian Ardakani, Associate Professor, Mohammad Reza Ravanbod, Associate Professor, Sharareh Seifi, Associate Professor, Mohammad Foratyazdi, Associate Professor, Seyed Asadollah Mousavi, Associate Professor, Mansour Rajabi Vahid, Associate Professor, Hossein Rahimi, Associate Professor, Mohammad Seghatoleslami, Post doctoral fellowship, Seyed Mohsen Razavi, Associate Professor, Amir Houshang Pourkhani, Associate Professor, Davoud Babakhani, Post doctoral fellowship, Nassim Anjidani, Pharm. D.

Connect to this object online.